P M Mendelman
Overview
Explore the profile of P M Mendelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Greenberg D, Yeh S, Yogev R, Reisinger K, Ward J, et al.
J Infect Dis
. 2001 Aug;
184(7):909-13.
PMID: 11509996
A phase 2 clinical trial was conducted to evaluate the antibody responses to bovine parainfluenza virus type 3 (bPIV3) vaccination in young infants. Three groups were tested as follows: placebo...
2.
Luce B, Zangwill K, Palmer C, Mendelman P, Yan L, Wolff M, et al.
Pediatrics
. 2001 Aug;
108(2):E24.
PMID: 11483834
Objective: Intranasal influenza vaccine has proven clinical efficacy and may be better tolerated by young children and their families than an injectable vaccine. This study determined the potential cost-effectiveness (CE)...
3.
Lee M, Mendelman P, Sangli C, Cho I, Mathie S, August M
J Infect Dis
. 2001 Mar;
183(8):1281-4.
PMID: 11262213
During a phase 2 trial of parainfluenza virus type 3 (PIV3) vaccine, sequential serum samples were obtained from infants at 2, 6, 7, 12-15, and 13-16 months of age. Paired...
4.
Mendelman P, Cordova J, Cho I
Vaccine
. 2001 Mar;
19(17-19):2221-6.
PMID: 11257337
Influenza is a major cause of illness. We have assessed the safety, efficacy, and effectiveness of CAIV-T vaccine. A two year, multicenter, double-blind, placebo-controlled, efficacy field trial in pre-school aged...
5.
Lehmann D, Kakazo M, Yarsley S, Javati A, Taime J, Saleu G, et al.
P N G Med J
. 2000 Aug;
41(3-4):102-11.
PMID: 10934551
Background: In view of high mortality and morbidity from Haemophilus influenzae type b (Hib) in young Papua New Guinean children, the incorporation of a Hib conjugate vaccine into a nationwide...
6.
Blum M, Dagan R, Mendelman P, Pinsk V, Giordani M, Li S, et al.
Vaccine
. 2000 Mar;
18(22):2359-67.
PMID: 10738092
Children who had been randomized to receive one dose of either heptavalent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine (PCV) or 23-valent pneumococcal polysaccharide vaccine (PN23) at 12, 15,...
7.
Belshe R, Gruber W, Mendelman P, Mehta H, Mahmood K, Reisinger K, et al.
J Infect Dis
. 2000 Mar;
181(3):1133-7.
PMID: 10720541
The authors conducted a 2-year, multicenter, double-blind, placebo-controlled efficacy field trial of live, attenuated, cold-adapted, trivalent influenza vaccine administered by nasal spray to children 15-71 months old. Overall, vaccine was...
8.
Longini I, Halloran M, Nizam A, Wolff M, Mendelman P, Fast P, et al.
Vaccine
. 2000 Mar;
18(18):1902-9.
PMID: 10699339
The authors provide an analysis of data from a two-year (1996-1998), multicenter (ten US cities), double-blinded, placebo-controlled influenza vaccine trial in children. The vaccine was the trivalent cold-adapted influenza vaccine....
9.
Belshe R, Gruber W, Mendelman P, Cho I, Reisinger K, Block S, et al.
J Pediatr
. 2000 Feb;
136(2):168-75.
PMID: 10657821
Objective: To determine the safety, immunogenicity, and efficacy of revaccination of children with live attenuated influenza vaccine. Study Design: A 2-year multicenter, double-blind, placebo-controlled, efficacy field trial of live attenuated,...
10.
Cha T, Kao K, Zhao J, Fast P, Mendelman P, Arvin A
J Clin Microbiol
. 2000 Feb;
38(2):839-45.
PMID: 10655394
An investigational live influenza virus vaccine, FluMist, contains three cold-adapted H1N1, H3N2, and B influenza viruses. The vaccine viruses are 6/2 reassortants, in which the hemagglutinin (HA) and neuraminidase (NA)...